Motley Rice member Fidelma Fitzpatrick stunned the tort bar with a $100 million verdict against Boston Scientific Corp. on May 28. It was the largest jury award to come out of the products liability litigation over mesh products implanted in women.

“A verdict of that size sends a clear message from the jury to the defendant about the defendant’s conduct, the defendant’s products, and the risks the defendant has going forward,” she said.